Sign in to view content

OTX-TKI for the Treatment of Neovascular Age-related Macular Degeneration 12-Month Results From a US Clinical Trial

Robert L. Avery, MD

Video
Published 2023

Related

Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
Jayanth Sridhar, MD
Member Podcasts
2018
One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Updates from the Field
2020
One-Year Outcome of Intravitreal Ziv-Aflibercept Therapy For Nonresponsive Neovascular Age-Related Macular Degeneration
Jay Chhablani, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more